HK1035368A1 - Prodrugs of proton pump inhibitors - Google Patents
Prodrugs of proton pump inhibitorsInfo
- Publication number
- HK1035368A1 HK1035368A1 HK01105985A HK01105985A HK1035368A1 HK 1035368 A1 HK1035368 A1 HK 1035368A1 HK 01105985 A HK01105985 A HK 01105985A HK 01105985 A HK01105985 A HK 01105985A HK 1035368 A1 HK1035368 A1 HK 1035368A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- proton pump
- prodrugs
- pump inhibitor
- drugs
- inhibitor drugs
- Prior art date
Links
- 229940126409 proton pump inhibitor Drugs 0.000 title abstract 5
- 239000000612 proton pump inhibitor Substances 0.000 title abstract 5
- 229940002612 prodrug Drugs 0.000 title abstract 4
- 239000000651 prodrug Substances 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 230000004962 physiological condition Effects 0.000 abstract 2
- HBDKFZNDMVLSHM-UHFFFAOYSA-N 2-(pyridin-2-ylmethylsulfinyl)-1h-benzimidazole Chemical compound N=1C2=CC=CC=C2NC=1S(=O)CC1=CC=CC=N1 HBDKFZNDMVLSHM-UHFFFAOYSA-N 0.000 abstract 1
- JJZPWCVHSLZLQC-UHFFFAOYSA-N [N].C1=CC=C2NC=NC2=C1 Chemical group [N].C1=CC=C2NC=NC2=C1 JJZPWCVHSLZLQC-UHFFFAOYSA-N 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Reciprocating Pumps (AREA)
- Fertilizing (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/131,481 US6093734A (en) | 1998-08-10 | 1998-08-10 | Prodrugs of proton pump inhibitors |
US36438199A | 1999-07-29 | 1999-07-29 | |
PCT/US1999/018048 WO2000009498A1 (fr) | 1998-08-10 | 1999-08-09 | Promedicaments d'inhibiteurs de la pompe a protons |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1035368A1 true HK1035368A1 (en) | 2001-11-23 |
Family
ID=26829517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01105985A HK1035368A1 (en) | 1998-08-10 | 2001-08-24 | Prodrugs of proton pump inhibitors |
Country Status (28)
Country | Link |
---|---|
US (1) | US6559167B1 (fr) |
EP (1) | EP1105387B1 (fr) |
JP (1) | JP4346243B2 (fr) |
KR (1) | KR100472126B1 (fr) |
CN (1) | CN100396675C (fr) |
AT (1) | ATE231857T1 (fr) |
AU (1) | AU752292B2 (fr) |
BG (1) | BG64870B1 (fr) |
BR (1) | BR9912937A (fr) |
CA (1) | CA2338311C (fr) |
DE (1) | DE69905171T2 (fr) |
DK (1) | DK1105387T3 (fr) |
ES (1) | ES2192394T3 (fr) |
FI (1) | FI20010248A (fr) |
HK (1) | HK1035368A1 (fr) |
HR (1) | HRP20010106A2 (fr) |
HU (1) | HUP0103464A3 (fr) |
ID (1) | ID28273A (fr) |
IL (2) | IL141083A0 (fr) |
IS (1) | IS5826A (fr) |
MX (1) | MXPA01001464A (fr) |
NO (1) | NO322490B1 (fr) |
NZ (1) | NZ510180A (fr) |
PL (1) | PL346000A1 (fr) |
TR (1) | TR200100431T2 (fr) |
UA (1) | UA67788C2 (fr) |
WO (1) | WO2000009498A1 (fr) |
YU (1) | YU10101A (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003043614A2 (fr) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Agents utiles pour le traitement des troubles des voies aeriennes |
MXPA05000657A (es) * | 2002-07-19 | 2005-08-19 | Winston Pharmaceuticals Llc | Profarmacos de los inhibidores de bomba de protones. |
JP2006188432A (ja) * | 2003-02-25 | 2006-07-20 | Zeria Pharmaceut Co Ltd | 四環系スルフェンアミド化合物 |
WO2005016917A1 (fr) | 2003-07-15 | 2005-02-24 | Allergan, Inc. | Procede de preparation de promedicaments isomeriquement purs d'inhibiteurs de la pompe a protons |
KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005039640A1 (fr) * | 2003-10-03 | 2005-05-06 | Allergan Inc. | Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
AU2005216862A1 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
CA2561700A1 (fr) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique |
ATE437869T1 (de) * | 2004-04-28 | 2009-08-15 | Hetero Drugs Ltd | Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere |
US7365206B2 (en) * | 2004-05-28 | 2008-04-29 | Hetero Drugs Limited | Stereoselective synthesis of benzimidazole sulfoxides |
BRPI0512261A (pt) * | 2004-06-17 | 2008-02-26 | Wyeth Corp | antagonistas de receptor de hormÈnio liberador de gonadotropina |
RU2007101509A (ru) * | 2004-06-17 | 2008-07-27 | Уайт (Us) | Способ получения антагонистов рецепторов гормона, высвобождающего гонадотропин |
AU2005286593A1 (en) * | 2004-09-23 | 2006-03-30 | Reddy Us Therapeutics, Inc. | Novel pyridine compounds, process for their preparation and compositions containing them |
MX2007005765A (es) * | 2004-11-23 | 2007-07-19 | Wyeth Corp | Antagonistas del receptor de la hormona que libera gonadotropina. |
US7582634B2 (en) * | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
US7534796B2 (en) * | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
US7538113B2 (en) * | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
US20060189619A1 (en) * | 2005-02-24 | 2006-08-24 | Wyeth | 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
US7582636B2 (en) * | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
US20090036406A1 (en) * | 2005-06-13 | 2009-02-05 | Takeda Pharmaceutical Company Limited | Injection |
WO2007073301A1 (fr) * | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Derives du benzoimidazole en tant que promedicaments d'inhibiteurs de la pompe a protons |
US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
WO2008036211A1 (fr) * | 2006-09-19 | 2008-03-27 | Alevium Pharmaceuticals, Inc. | Promédicaments d'inhibiteurs de pompes à protons comprenant le groupe fonctionnel (1h-pyrrol-1-yl)-1h-benzimidazole |
CA2667682A1 (fr) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprenant des agents d'inhibition de la pompe a protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procedes d'utilisation |
CN101497622B (zh) * | 2008-01-30 | 2011-04-27 | 山东轩竹医药科技有限公司 | 吡啶甲基亚磺酰基咪唑并吡啶衍生物 |
CA2716367C (fr) | 2008-02-20 | 2015-05-26 | The Curators Of The University Of Missouri | Composition comprenant une combinaison d'omeprazole et de lansoprazole, et un agent tampon, et ses methodes d'utilisation |
UA100192C2 (en) * | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
EP2921479B1 (fr) * | 2012-11-19 | 2017-02-01 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Dérivé pyrrole sulfonamide, procédé de préparation et application médicale associés |
CN105143187B (zh) | 2013-02-28 | 2018-04-03 | 武田药品工业株式会社 | 制备磺酰氯化合物的方法 |
EP3762368B1 (fr) | 2018-03-08 | 2022-01-26 | Incyte Corporation | Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
WO2021234002A1 (fr) | 2020-05-20 | 2021-11-25 | F. Hoffmann-La Roche Ag | Réactif pour la spectrométrie de masse |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
FI90544C (fi) | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
HUT62882A (en) * | 1990-06-20 | 1993-06-28 | Astra Ab | Process for producing dialkoxy pyridylmethyl sulfinyl benzimidazole derivatives and pharmaceutical compositions comprising same |
SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
WO1995029897A1 (fr) * | 1994-04-29 | 1995-11-09 | G.D. Searle & Co. | Procede d'utilisation d'inhibiteurs de (h+/k+)atpase comme agents antiviraux |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
SE9602442D0 (sv) | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
-
1999
- 1999-08-09 YU YU10101A patent/YU10101A/sh unknown
- 1999-08-09 ES ES99942057T patent/ES2192394T3/es not_active Expired - Lifetime
- 1999-08-09 PL PL99346000A patent/PL346000A1/xx not_active IP Right Cessation
- 1999-08-09 EP EP99942057A patent/EP1105387B1/fr not_active Expired - Lifetime
- 1999-08-09 KR KR10-2001-7001705A patent/KR100472126B1/ko not_active IP Right Cessation
- 1999-08-09 ID IDW20010545A patent/ID28273A/id unknown
- 1999-08-09 AU AU55518/99A patent/AU752292B2/en not_active Expired
- 1999-08-09 BR BR9912937-0A patent/BR9912937A/pt not_active Application Discontinuation
- 1999-08-09 DK DK99942057T patent/DK1105387T3/da active
- 1999-08-09 AT AT99942057T patent/ATE231857T1/de not_active IP Right Cessation
- 1999-08-09 WO PCT/US1999/018048 patent/WO2000009498A1/fr active IP Right Grant
- 1999-08-09 IL IL14108399A patent/IL141083A0/xx active IP Right Grant
- 1999-08-09 TR TR2001/00431T patent/TR200100431T2/xx unknown
- 1999-08-09 NZ NZ510180A patent/NZ510180A/xx not_active IP Right Cessation
- 1999-08-09 CA CA002338311A patent/CA2338311C/fr not_active Expired - Lifetime
- 1999-08-09 HU HU0103464A patent/HUP0103464A3/hu unknown
- 1999-08-09 MX MXPA01001464A patent/MXPA01001464A/es not_active IP Right Cessation
- 1999-08-09 DE DE69905171T patent/DE69905171T2/de not_active Expired - Lifetime
- 1999-08-09 CN CNB998095125A patent/CN100396675C/zh not_active Expired - Fee Related
- 1999-08-09 JP JP2000564950A patent/JP4346243B2/ja not_active Expired - Fee Related
- 1999-09-08 UA UA2001020908A patent/UA67788C2/uk unknown
-
2001
- 2001-01-24 IL IL141083A patent/IL141083A/en not_active IP Right Cessation
- 2001-01-26 IS IS5826A patent/IS5826A/is unknown
- 2001-01-26 BG BG105191A patent/BG64870B1/bg unknown
- 2001-02-09 HR HR20010106A patent/HRP20010106A2/hr not_active Application Discontinuation
- 2001-02-09 NO NO20010693A patent/NO322490B1/no not_active IP Right Cessation
- 2001-02-09 FI FI20010248A patent/FI20010248A/fi unknown
- 2001-02-14 US US09/783,807 patent/US6559167B1/en not_active Expired - Lifetime
- 2001-08-24 HK HK01105985A patent/HK1035368A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1035368A1 (en) | Prodrugs of proton pump inhibitors | |
TR200103493T2 (tr) | Metaloproteaz önleyicileri | |
MY121389A (en) | Imidazo pyridine derivatives which inhibit gastric acid secretion | |
NO20014046L (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
PT1147110E (pt) | Derivados de pirazino (aza)-indol | |
HUP0102250A2 (hu) | Nemstabilis dipeptidilpeptidáz IV-gátlók vegyületei, azokat tartalmazó gyógyászati készítmények és alkalmazásuk | |
TR200201144T2 (tr) | NFKB aktivitesinin modülasyonu için ikame edilmiş indoller | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
NO20051892L (no) | Ny forbindelse | |
IN2005KO00312A (fr) | ||
ZA200501116B (en) | Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor | |
HK1087702A1 (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
TR200101120T2 (tr) | Serin proteaz inhibitörü | |
NO20016201L (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
SE9802793D0 (sv) | New compounds | |
AR028641A1 (es) | MÉTODOS PARA LA PREVENCION DE uLCERAS Y MEJORA DE LA PERFORMANCE FISIOLoGICA | |
MX2007006069A (es) | Metodos para utilizar inhibidores de la fosfodiesterasa tipo v y para el tratamiento de insuficiencia cardiaca congestiva. | |
PT1178960E (pt) | Analogos da vitamina d e sua utilizacao farmaceutica | |
AU2003216965A1 (en) | Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases | |
ATE395060T1 (de) | Verwendung von tenatoprazol zur behandlung von gastroösophogalem reflux | |
DK1220844T3 (da) | Arylsulfonamid-substituerede benzimidazolderivater og deres anvendelse som tryptase-inhibitorer | |
SE9904483D0 (sv) | New use | |
AU7905500A (en) | Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors | |
MXPA04005310A (es) | Inhibidores de fosfolipasa a2 citosolica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110809 |